Clopidogrel, a P2Y12 antagonist, has a very significant effect on platelet aggregation by covalently binding to its cysteine residue to form an irreversible bond.
Clopidogrel is a P2Y12 antagonist, which forms an irreversible binding through covalent binding with its cysteine residues. It plays a very significant role in anti platelet aggregation.
Clopidogrel is a P2Y12 antagonist, which forms an irreversible combination through covalent binding with its cysteine residue, and has a very significant effect on anti-platelet aggregation.